Agnès Gouble is a VP of Program Management at Coave Therapeutics, where they focus on developing gene therapies using conjugated AAVs to treat ocular and CNS diseases. With a PhD and 20 years of industry experience in gene and cell therapy development, Agnès previously led non-clinical activities at Cellectis, contributing notably to the UCART products. Their career includes roles as an R&D team manager and scientific alliance manager, demonstrating expertise in molecular biology, project management, and preclinical strategy.
This person is not in any teams
This person is not in any offices